Patient compliance for metabolic evaluation and medical treatment (CoMET) in calcium-oxalate stone patients: prospective study by EULIS eCORE study group.
Adherence to diet
Adherence to medication
Metabolic evaluation
Preventive pharmacotherapy
Urolithiasis
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
06
03
2023
accepted:
31
08
2023
medline:
9
11
2023
pubmed:
28
9
2023
entrez:
27
9
2023
Statut:
ppublish
Résumé
In this study, we aimed to identify the compliance rates of calcium-oxalate stone patients for metabolic evaluation, diet and medical treatment and also determine the factors that are associated with poor compliance rates. This study was conducted by the EULIS eCORE working group prospectively. In the initial visit, demographic and stone-related characteristics were recorded. Patients were suggested metabolic evaluation, dietary advices and medical treatment. Follow-up visit was performed after 3 months and compliance rates were recorded. Logistic regression analysis was performed to determine factors associated with poor compliance to metabolic evaluation, diet and medical treatment. Data of 346 patients from nine centers were analyzed. Compliance rates were 71.7%, 65.3%, and 63.7% for metabolic evaluation, diet, and medical treatment, respectively. In multivariate analysis, level of education (p = 0.003), history of emergency department visit (p = 0.04), number of stone surgeries (p = 0.03), patient care in dedicated stone clinic (p = 0.03), and history of shock wave lithotripsy (p = 0.005) were detected as independent predictors of compliance to metabolic analysis. Level of education (p < 0.001) and history of emergency department visit (p = 0.01) were detected as independent predictors of patient compliance to diet. Number of stone episodes (p = 0.03), family history of stones (p = 0.02), and polypharmacy (p < 0.001) were detected as independent predictors of patient compliance to medical treatment. Patient compliance to metabolic evaluation, diet, and medical therapy is important for successful management of urolithiasis. Dietary advices and medications should be personalized by taking in to account the factors associated with poor compliance.
Identifiants
pubmed: 37758934
doi: 10.1007/s00345-023-04610-w
pii: 10.1007/s00345-023-04610-w
doi:
Substances chimiques
Calcium
SY7Q814VUP
Calcium Oxalate
2612HC57YE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3135-3140Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Tiselius HG (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44(1):91–100
doi: 10.1007/s00240-015-0840-y
pubmed: 26614110
Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50(5):1706–1712
doi: 10.1038/ki.1996.489
pubmed: 8914040
Kocvara R, Plasgura P, Petrik A et al (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 84(4):393–398
doi: 10.1046/j.1464-410x.1999.00216.x
pubmed: 10468751
Bensalah K, Tuncel A, Raman JD et al (2009) How physician and patient perceptions differ regarding medical management of stone disease. J Urol 182(3):998–1004
doi: 10.1016/j.juro.2009.05.025
pubmed: 19616801
Parks JH, Asplin JR, Coe FL (2001) Patient adherence to long-term medical treatment of kidney stones. J Urol 166(6):2057–2060
doi: 10.1016/S0022-5347(05)65505-X
pubmed: 11696706
Dauw CA, Yi Y, Bierlein MJ et al (2016) Medication nonadherence and effectiveness of preventive pharmacological therapy for kidney stones. J Urol 195(3):648–652
doi: 10.1016/j.juro.2015.10.082
pubmed: 26485048
Hess B (2017) Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations. Urolithiasis 45(4):363–370
doi: 10.1007/s00240-016-0916-3
pubmed: 27573100
Ruppar TM (2012) Medication adherence research: essential to improving health. West J Nurs Res 34(5):575–577
doi: 10.1177/0193945912442478
pubmed: 22735642
Whitehurst L, Jones P, Somani BK (2019) Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review. World J Urol 37(5):759–776
doi: 10.1007/s00345-018-2424-2
pubmed: 30151599
Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324
doi: 10.1016/j.juro.2014.05.006
pubmed: 24857648
European Association of Urology. EAU guidelines Urolithiasis 2023 [23.04.2023]. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urolithiasis-2023.pdf . Accessed 23 Apr 2023
Dauw CA, Alruwaily AF, Bierlein MJ et al (2015) Provider variation in the quality of metabolic stone management. J Urol 193(3):885–890
doi: 10.1016/j.juro.2014.09.111
pubmed: 25286012
Gokce MI, Wang X, Frost J et al (2016) Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men. Cancer 123(4):583–591
doi: 10.1002/cncr.30367
pubmed: 27727462
Volk RJ, Spann SJ, Cass AR et al (2003) Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med 1(1):22–28
doi: 10.1370/afm.7
pubmed: 15043176
pmcid: 1466553
Gokce MI, Esen B, Sanci A et al (2017) A novel decision aid to support informed decision-making process in patients with a symptomatic nonlower pole renal stone <20 mm in diameter. J Endourol 31(7):725–728
doi: 10.1089/end.2017.0077
pubmed: 28467724
Hess B, Mauron H, Ackermann D et al (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 36(2):136–143
doi: 10.1159/000067985
pubmed: 10420035
Sromicki J, Hess B (2020) Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers. Urolithiasis 48(5):425–433
doi: 10.1007/s00240-020-01194-7
pubmed: 32524204
pmcid: 7495994
Simon ST, Kini V, Levy AE et al (2021) Medication adherence in cardiovascular medicine. BMJ 374:n1493
doi: 10.1136/bmj.n1493
pubmed: 34380627
Mignat C, Unger T (1995) ACE inhibitors. Drug interactions of clinical significance. Drug Saf 12(5):334–47
doi: 10.2165/00002018-199512050-00005
pubmed: 7669262